Last reviewed · How we verify
Benzedrex (PROPYLHEXEDRINE)
Propylhexedrine, marketed as Benzedrex, is a nasal decongestant currently available in the over-the-counter market. Its key strength lies in its mechanism of action, which effectively stimulates the nasal mucosa to reduce swelling and increase airflow, providing rapid relief for nasal congestion. The primary risk is the key composition patent expiry in 2028, which could lead to increased competition from generic alternatives.
At a glance
| Generic name | PROPYLHEXEDRINE |
|---|---|
| Drug class | propylhexedrine |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
| Annual revenue | 172 |
Approved indications
- Nasal Congestion Relief
Common side effects
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| SEC EDGAR | Revenue + earnings |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Benzedrex CI brief — competitive landscape report
- Benzedrex updates RSS · CI watch RSS